Bioconnect Systems
Ambler, US · 1 known investors
Biotech
Founders & leadership
MD
Michael DugeryNamed on SEC filing
RW
Robert WeisskoffNamed on SEC filing
AD
Adam D. DakinNamed on SEC filing
CG
Charles G. HadleyNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$469.2K disclosed across 1 round · 2012
▶$469.2KraisedJan 2012 · 6 investors · BiotechnologyRule 506(b)
▶$469.2KraisedJan 2012 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael DugeryExecutive Officer, Director
- Robert WeisskoffDirector
- Adam D. DakinExecutive Officer, Director
- Charles G. HadleyDirector
- Offering amount
- $938.4K
- Amount sold
- $469.2K
- Minimum investment
- $1.4K
- Proceeds to insiders
- $125K
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.